Stryker to buy Amplitude Vascular Systems

Stryker to buy Amplitude Vascular Systems

Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.

Stryker signs definitive agreement to acquire Amplitude Vascular Systems

Stryker revealed this week that it has signed a definitive agreement to acquire Amplitude Vascular Systems (AVS), which is developing a next-generation intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease (PAD). A press release notes that the acquisition will strengthen Stryker’s peripheral vascular portfolio by adding revascularisation technology. Once cleared for use in applicable markets, the produc…

Stryker to Acquire Amplitude Vascular Systems

April 13, 2026—Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a privately held company developing a next-generation intravascular lithotripsy (IVL) platform to treat calcified peripheral artery disease. Stryker stated that the acquisition is intended to strengthen its peripheral vascular (PV) portfolio by adding revascularization technology. According to Stryker, AVS’s IVL …

Stryker agrees to acquire IVL developer Amplitude Vascular Systems

Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.The post Stryker agrees to acquire IVL developer Amplitude Vascular Systems appeared first on Medical Device Network.